UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM N-CSRS
Investment Company Act file number: 811-00043
Deutsche DWS Investment Trust
(Exact Name of Registrant as Specified in Charter)
875 Third Avenue
New York, NY 10022-6225
(Address of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, including Area Code: (212) 454-4500
Diane Kenneally
One International Place
Boston, MA 02110
(Name and Address of Agent for Service)
Date of fiscal year end: | 9/30 |
Date of reporting period: | 3/31/2020 |
ITEM 1. | REPORT TO STOCKHOLDERS |
This report must be preceded or accompanied by a prospectus. To obtain a summary prospectus, if available, or prospectus for any of our funds, refer to the Account Management Resources information provided in the back of this booklet. We advise you to consider the Funds objectives, risks, charges and expenses carefully before investing. The summary prospectus and prospectus contain this and other important information about the Fund. Please read the prospectus carefully before you invest.
The Fund will be managed using the CROCI® Investment Process which is based on portfolio managements belief that, over time, stocks which display more favorable financial metrics (for example, the CROCI® Economic P/E Ratio) as generated by this process may outperform stocks which display less favorable metrics. This premise may not prove to be correct and prospective investors should evaluate this assumption prior to investing in the Fund. Stocks may decline in value. The Fund may lend securities to approved institutions. Please read the prospectus for details.
War, terrorism, economic uncertainty, trade disputes, public health crises (including the recent pandemic spread of the novel coronavirus) and related geopolitical events could lead to increased market volatility, disruption to U.S. and world economies and markets and may have significant adverse effects on the Fund and its investments.
The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services.
NOT FDIC/NCUA INSURED NO BANK GUARANTEE MAY LOSE VALUE NOT A DEPOSIT NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY
2 | | | DWS CROCI® U.S. Fund |
Dear Shareholder:
While the economy isnt expected to shrug off the impacts of the COVID-19 pandemic easily, DWSs CIO Office is cautiously optimistic. Our CIO Office anticipates the recession in the United States (U.S.) to be shallower than in the Eurozone, followed by a more robust U.S. recovery primarily benefiting from the outsized U.S. fiscal stimulus. Our CIO office sees long-lasting disruptions of supply chains and consumer spending, potentially derailing the current outlook.
What is already becoming clear is the current assessment of the situation by financial markets. As of mid-May, U.S. markets have moved from panic mode back to relatively high valuations. However, sentiment can quickly change and March lows may be tested again in the coming months. With respect to the bond markets, we think that accommodative central bank action will continue or even accelerate, with the interest rates set to remain low for the foreseeable future.
What may come next? In the short term, we expect markets to remain volatile. While our strategists forecast peaking uncertainty on stock markets, sharp setbacks could happen at any time. Stocks have become even more appealing for the medium to long term time horizons, due to the very accommodative monetary policy of the leading central banks and growing fiscal deficits.
As the U.S. and global economies forge a path to recovery, close monitoring of developments to assess potential opportunities and risks is critical. We believe the unique structure of our CIO Office which synthesizes the views of more than 900 DWS economists, analysts and investment professionals around the world perfectly positions us to make strategic and tactical decisions. Those insights are updated frequently and are always available on the Insights section of dws.com.
As always, we appreciate your trust and welcome the opportunity to help you navigate these unusual times. We believe our decades of experience in managing assets through multiple market cycles and events will add value in times such as these.
Best regards,
Hepsen Uzcan
President, DWS Funds |
Assumptions, estimates and opinions contained in this document constitute our judgment as of the date of the document and are subject to change without notice. Any projections are based on a number of assumptions as to market conditions and there can be no guarantee that any projected results will be achieved. Past performance is not a guarantee of future results.
DWS CROCI® U.S. Fund | | | 3 |
Performance Summary | March 31, 2020 (Unaudited) |
Class A | 6-Month | 1-Year | Life of Fund* | |||||||||
Average Annual Total Returns as of 3/31/20 | ||||||||||||
Unadjusted for Sales Charge | 24.33% | 20.31% | 1.01% | |||||||||
Adjusted for the Maximum Sales Charge (max 5.75% load) |
28.68% | 24.89% | 2.18% | |||||||||
Russell 1000® Value Index | 21.30% | 17.17% | 1.60% | |||||||||
S&P 500® Index | 12.31% | 6.98% | 6.41% | |||||||||
Class T | 6-Month | 1-Year | Life of Fund* | |||||||||
Average Annual Total Returns as of 3/31/20 | ||||||||||||
Unadjusted for Sales Charge | 24.25% | 20.16% | 1.02% | |||||||||
Adjusted for the Maximum Sales Charge (max 2.50% load) |
26.14% | 22.15% | 1.53% | |||||||||
Russell 1000® Value Index | 21.30% | 17.17% | 2.52% | |||||||||
S&P 500® Index | 12.31% | 6.98% | 4.11% | |||||||||
Class C | 6-Month | 1-Year | Life of Fund* | |||||||||
Average Annual Total Returns as of 3/31/20 | ||||||||||||
Unadjusted for Sales Charge | 24.62% | 20.85% | 1.76% | |||||||||
Adjusted for the Maximum Sales Charge (max 1.00% CDSC) |
25.34% | 20.85% | 1.76% | |||||||||
Russell 1000® Value Index | 21.30% | 17.17% | 1.60% | |||||||||
S&P 500® Index | 12.31% | 6.98% | 6.41% | |||||||||
Class R | 6-Month | 1-Year | Life of Fund* | |||||||||
Average Annual Total Returns as of 3/31/20 | ||||||||||||
Unadjusted for Sales Charge | 24.43% | 20.55% | 1.37% | |||||||||
Russell 1000® Value Index | 21.30% | 17.17% | 1.17% | |||||||||
S&P 500® Index | 12.31% | 6.98% | 6.42% | |||||||||
Class R6 | 6-Month | 1-Year | Life of Fund* | |||||||||
Average Annual Total Returns as of 3/31/20 | ||||||||||||
Unadjusted for Sales Charge | 24.12% | 19.89% | 0.66% | |||||||||
Russell 1000® Value Index | 21.30% | 17.17% | 1.60% | |||||||||
S&P 500® Index | 12.31% | 6.98% | 6.41% |
4 | | | DWS CROCI® U.S. Fund |
Class S | 6-Month | 1-Year | Life of Fund* | |||||||||
Average Annual Total Returns as of 3/31/20 | ||||||||||||
Unadjusted for Sales Charge | 24.12% | 19.95% | 0.73% | |||||||||
Russell 1000® Value Index | 21.30% | 17.17% | 1.60% | |||||||||
S&P 500® Index | 12.31% | 6.98% | 6.41% | |||||||||
Institutional Class | 6-Month | 1-Year | Life of Fund* | |||||||||
Average Annual Total Returns as of 3/31/20 | ||||||||||||
Unadjusted for Sales Charge | 24.16% | 20.06% | 0.74% | |||||||||
Russell 1000® Value Index | 21.30% | 17.17% | 1.60% | |||||||||
S&P 500® Index | 12.31% | 6.98% | 6.41% |
Performance in the Average Annual Total Returns table above and the Growth of an Assumed $10,000 Investment line graph that follows is historical and does not guarantee future results. Investment return and principal fluctuate, so your shares may be worth more or less when redeemed. Current performance may differ from performance data shown. Please visit dws.com for the Funds most recent month-end performance. Fund performance includes reinvestment of all distributions. Unadjusted returns do not reflect sales charges and would have been lower if they had.
The gross expense ratios of the Fund, as stated in the fee table of the prospectus dated February 1, 2020 are 0.99%, 0.92%, 1.73%, 1.34%, 0.64%, 0.67% and 0.71% for Class A, Class T, Class C, Class R, Class R6, Class S and Institutional Class shares, respectively, and may differ from the expense ratios disclosed in the Financial Highlights tables in this report.
Index returns do not reflect any fees or expenses and it is not possible to invest directly into an index.
Performance figures do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares.
Returns shown for Class T shares for the period prior to its inception on June 5, 2017 are derived from the historical performance of Institutional Class shares of DWS CROCI® U.S. Fund during such periods and have been adjusted to reflect the higher total annual operating expenses and applicable sales charges of Class T. Any difference in expenses will affect performance.
Returns shown for Class R shares for the period prior to its inception on December 9, 2016 are derived from the historical performance of Institutional Class shares of DWS CROCI® U.S. Fund during such periods and have been adjusted to reflect the higher total annual operating expenses of Class R. Any difference in expenses will affect performance.
Generally accepted accounting principles require adjustments to be made to the net assets of the Fund at period end for financial reporting purposes only, and as such, the total return based on the unadjusted net asset value per share may differ from the total return reported in the financial highlights.
DWS CROCI® U.S. Fund | | | 5 |
Growth of an Assumed $10,000 Investment (Adjusted for Maximum Sales Charge) |
The Funds growth of an assumed $10,000 investment is adjusted for the maximum sales charge of 5.75%. This results in a net investment of $9,425.
The growth of $10,000 is cumulative.
Performance of other share classes will vary based on the sales charges and the fee structure of those classes.
* | Deutsche CROCI® U.S. Fund commenced operations on April 13, 2015. Class T shares commenced operations on June 5, 2017. Class R shares commenced operations on December 9, 2016. |
| Russell 1000® Value Index is an unmanaged market capitalization-weighted index of value-oriented stocks of the largest U.S. domiciled companies that are included in the Russell 1000 Index. Value-oriented stocks tend to have lower price-to-book ratios and lower forecasted growth values. Russell 1000® Index is an unmanaged price-only index of the 1,000 largest capitalized companies that are domiciled in the U.S. and whose common stocks are traded. |
| Standard & Poors 500® Index (S&P 500®) is an unmanaged, capitalization-weighted index of 500 stocks. The index is designed to measure performance of the broad domestic economy through changes in the aggregate market value of 500 stocks representing all major industries. |
| Total returns shown for periods less than one year are not annualized. |
Effective December 1, 2019, the Russell 1000® Value Index has replaced the S&P 500® Index as the funds primary benchmark index. The Advisor believes that the new index better represents the funds investment strategy and is therefore more suitable for performance comparison.
6 | | | DWS CROCI® U.S. Fund |
Class A | Class T | Class C | Class R | Class R6 | Class S | Institutional Class |
||||||||||||||||||||||
Net Asset Value | ||||||||||||||||||||||||||||
3/31/20 | $ | 8.37 | $ | 8.38 | $ | 8.29 | $ | 8.37 | $ | 8.38 | $ | 8.38 | $ | 8.37 | ||||||||||||||
9/30/19 | $ | 11.70 | $ | 11.71 | $ | 11.55 | $ | 11.68 | $ | 11.73 | $ | 11.73 | $ | 11.72 | ||||||||||||||
Distribution Information as of 3/31/20 |
| |||||||||||||||||||||||||||
Income Distributions, Six Months | $ | .19 | $ | .20 | $ | .10 | $ | .16 | $ | .25 | $ | .24 | $ | .23 | ||||||||||||||
Capital Gain Distributions, Six Months | $ | .51 | $ | .51 | $ | .51 | $ | .51 | $ | .51 | $ | .51 | $ | .51 |
DWS CROCI® U.S. Fund | | | 7 |
Di Kumble, CFA, Managing Director
Portfolio Manager of the Fund. Began managing the Fund in 2015.
| Joined DWS in 2003 with seven years of industry experience. Prior to joining, she served as a Portfolio Manager at Graham Capital Management. Previously, she worked as a Quantitative Strategist at ITG Inc. and Morgan Stanley. |
| Senior Portfolio Manager, Head of Tax Managed Equities: New York. |
| BS, Beijing University; PhD in Chemistry, Princeton University. |
John Moody, Vice President
Portfolio Manager of the Fund. Began managing the Fund in 2016.
| Joined DWS in 1998. Prior to his current role, served as a Business Manager for Active Equity. Previously, he was a Portfolio Analyst for EAFE, Global and Technology Funds and an Investment Accountant for International Funds. He began his career as a Client Service Associate for the International Institutional Equity Group. |
| Portfolio Analyst/Portfolio Manager: New York. |
| BS in Business Management, Fairfield University. |
8 | | | DWS CROCI® U.S. Fund |
Ten Largest Equity Holdings at March 31, 2020 (33.0% of Net Assets) | ||||||
1 | Regeneron Pharmaceuticals, Inc. | 4.3% | ||||
Operator of a drug research and development company | ||||||
2 | Cabot Oil & Gas Corp. | 3.9% | ||||
Explorer and producer of oil and gas | ||||||
3 | Gilead Sciences, Inc. | 3.9% | ||||
Developer of nucleotide pharmaceuticals | ||||||
4 | Merck & Co., Inc. | 3.2% | ||||
Global pharmaceutical company | ||||||
5 | Pfizer, Inc. | 3.1% | ||||
Manufacturer of prescription pharmaceuticals and nonprescription self-medications | ||||||
6 | Alexion Pharmaceuticals, Inc. | 3.1% | ||||
Developer of immunoregulatory compounds | ||||||
7 | Bristol-Myers Squibb Co. | 2.9% | ||||
Producer of diversified pharmaceuticals and other products | ||||||
8 | Consolidated Edison, Inc. | 2.9% | ||||
Provider of electric utilities | ||||||
9 | PACCAR, Inc. | 2.9% | ||||
Provider of machinery services | ||||||
10 | Dominion Energy, Inc | 2.8% | ||||
Operator of diversified utility holding business in Virginia |
Portfolio holdings and characteristics are subject to change.
For more complete details about the Funds investment portfolio, see page 10. A quarterly Fact Sheet is available on dws.com or upon request. Please see the Account Management Resources section on page 43 for contact information.
DWS CROCI® U.S. Fund | | | 9 |
Investment Portfolio | as of March 31, 2020 (Unaudited) |
Shares | Value ($) | |||||||
Common Stocks 97.2% | ||||||||
Communication Services 6.2% | ||||||||
Media |
||||||||
Comcast Corp. A |
432,232 | 14,860,136 | ||||||
Discovery, Inc. A* (a) |
656,212 | 12,756,761 | ||||||
ViacomCBS, Inc. B |
565,487 | 7,922,473 | ||||||
|
|
|||||||
35,539,370 | ||||||||
Consumer Discretionary 4.4% | ||||||||
Auto Components 2.5% |
||||||||
BorgWarner, Inc. |
580,886 | 14,156,192 | ||||||
Household Durables 1.9% |
||||||||
D.R. Horton, Inc. |
320,758 | 10,905,772 | ||||||
Energy 4.0% | ||||||||
Oil, Gas & Consumable Fuels |
||||||||
Cabot Oil & Gas Corp. |
1,312,857 | 22,568,012 | ||||||
Financials 28.2% | ||||||||
Banks 20.6% |
||||||||
Bank of America Corp. |
581,653 | 12,348,493 | ||||||
Citigroup, Inc. |
255,536 | 10,763,176 | ||||||
Citizens Financial Group, Inc. |
526,326 | 9,900,192 | ||||||
Comerica, Inc. |
323,452 | 9,490,082 | ||||||
Huntington Bancshares, Inc. |
1,441,139 | 11,831,751 | ||||||
JPMorgan Chase & Co. |
146,649 | 13,202,810 | ||||||
M&T Bank Corp. |
119,434 | 12,353,059 | ||||||
PNC Financial Services Group, Inc. |
131,915 | 12,626,904 | ||||||
U.S. Bancorp. |
368,278 | 12,687,177 | ||||||
Wells Fargo & Co. |
425,209 | 12,203,498 | ||||||
|
|
|||||||
117,407,142 | ||||||||
Capital Markets 2.6% |
||||||||
Bank of New York Mellon Corp. |
436,271 | 14,693,607 | ||||||
Consumer Finance 5.0% |
||||||||
Capital One Financial Corp. |
194,369 | 9,800,085 | ||||||
Discover Financial Services |
263,730 | 9,407,249 | ||||||
Synchrony Financial |
594,375 | 9,563,494 | ||||||
|
|
|||||||
28,770,828 | ||||||||
Health Care 20.5% | ||||||||
Biotechnology 11.2% |
||||||||
Alexion Pharmaceuticals, Inc.* |
194,722 | 17,484,088 | ||||||
Gilead Sciences, Inc. |
295,241 | 22,072,217 | ||||||
Regeneron Pharmaceuticals, Inc.* |
49,779 | 24,306,588 | ||||||
|
|
|||||||
63,862,893 |
The accompanying notes are an integral part of the financial statements.
10 | | | DWS CROCI® U.S. Fund |
Shares | Value ($) | |||||||
Pharmaceuticals 9.3% |
||||||||
Bristol-Myers Squibb Co. |
299,634 | 16,701,599 | ||||||
Merck & Co., Inc. |
240,889 | 18,534,000 | ||||||
Pfizer, Inc. |
546,180 | 17,827,315 | ||||||
|
|
|||||||
53,062,914 | ||||||||
Industrials 13.0% |
| |||||||
Airlines 3.1% |
||||||||
Delta Air Lines, Inc. |
337,512 | 9,629,217 | ||||||
United Airlines Holdings, Inc.* (a) |
250,947 | 7,917,378 | ||||||
|
|
|||||||
17,546,595 | ||||||||
Building Products 2.2% |
||||||||
Johnson Controls International plc |
476,571 | 12,848,354 | ||||||
Machinery 5.7% |
||||||||
Cummins, Inc. |
120,289 | 16,277,507 | ||||||
PACCAR, Inc. |
267,782 | 16,369,514 | ||||||
|
|
|||||||
32,647,021 | ||||||||
Professional Services 2.0% |
||||||||
ManpowerGroup, Inc. |
217,062 | 11,502,116 | ||||||
Information Technology 2.4% | ||||||||
Technology Hardware, Storage & Peripherals |
||||||||
Hewlett Packard Enterprise Co. |
1,384,317 | 13,441,718 | ||||||
Utilities 18.5% | ||||||||
Electric Utilities 7.7% |
||||||||
Duke Energy Corp. |
194,521 | 15,732,858 | ||||||
Exelon Corp. |
394,575 | 14,524,306 | ||||||
PPL Corp. |
556,134 | 13,725,387 | ||||||
|
|
|||||||
43,982,551 | ||||||||
Multi-Utilities 10.8% |
||||||||
Consolidated Edison, Inc. |
210,296 | 16,403,088 | ||||||
Dominion Energy, Inc |
225,526 | 16,280,722 | ||||||
DTE Energy Co. |
147,029 | 13,963,344 | ||||||
Public Service Enterprise Group, Inc. |
336,796 | 15,125,509 | ||||||
|
|
|||||||
61,772,663 | ||||||||
|
||||||||
Total Common Stocks (Cost $758,785,214) |
|
554,707,748 | ||||||
Securities Lending Collateral 2.5% | ||||||||
DWS Government & Agency Securities Portfolio DWS Government Cash Institutional Shares, 0.33% (b) (c) (Cost $14,343,595) |
14,343,595 | 14,343,595 |
The accompanying notes are an integral part of the financial statements.
DWS CROCI® U.S. Fund | | | 11 |
Shares | Value ($) | |||||||
Cash Equivalents 2.7% | ||||||||
DWS Central Cash Management Government Fund, 0.32% (b) (Cost $15,662,493) |
15,662,493 | 15,662,493 | ||||||
% of Net Assets |
Value ($) | |||||||
Total Investment Portfolio (Cost $788,791,302) | 102.4 | 584,713,836 | ||||||
Other Assets and Liabilities, Net | (2.4 | ) | (13,530,187 | ) | ||||
|
||||||||
Net Assets | 100.0 | 571,183,649 |
A summary of the Funds transactions with affiliated investments during the period ended March 31, 2020 are as follows:
Value ($) at 9/30/2019 |
Pur- chases Cost ($) |
Sales Proceeds ($) |
Net Real- ized Gain/ (Loss) ($) |
Net Change in Unreal- ized Appreci- ation (Depreci- ation) ($) |
Income ($) |
Capital Gain Distri- butions ($) |
Number of Shares at 3/31/2020 |
Value ($) at 3/31/2020 |
||||||||||||||||||||||||||
Securities Lending Collateral 2.5% | ||||||||||||||||||||||||||||||||||
DWS Government & Agency Securities Portfolio DWS Government Cash Institutional Shares, 0.33% (b) (c) | ||||||||||||||||||||||||||||||||||
| 14,343,595 (d) | | | | 3,319 | | 14,343,595 | 14,343,595 | ||||||||||||||||||||||||||
Cash Equivalents 2.7% | ||||||||||||||||||||||||||||||||||
DWS Central Cash Management Government Fund, (b) 0.32% | ||||||||||||||||||||||||||||||||||
2,372,496 | 51,755,023 | 38,465,026 | | | 40,620 | | 15,662,493 | 15,662,493 | ||||||||||||||||||||||||||
2,372,496 | 66,098,618 | 38,465026 | | | 43,939 | | 30,006,088 | 30,006,088 |
* | Non-income producing security. |
(a) | All or a portion of these securities were on loan. In addition, Other Assets and Liabilities, Net may include pending sales that are also on loan. The value of securities loaned at March 31, 2020 amounted to $13,877,209, which is 2.4% of net assets. |
(b) | Affiliated fund managed by DWS Investment Management Americas, Inc. The rate shown is the annualized seven-day yield at period end. |
(c) | Represents cash collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates. |
(d) | Represents the net increase (purchase cost) or decrease (sales proceeds) in the amount invested in cash collateral for the period ended March 31, 2020. |
The accompanying notes are an integral part of the financial statements.
12 | | | DWS CROCI® U.S. Fund |
Fair Value Measurements
Various inputs are used in determining the value of the Funds investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Funds own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
The following is a summary of the inputs used as of March 31, 2020 in valuing the Funds investments. For information on the Funds policy regarding the valuation of investments, please refer to the Security Valuation section of Note A in the accompanying Notes to Financial Statements.
Assets | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Common Stocks (e) | $ | 554,707,748 | $ | | $ | | $ | 554,707,748 | ||||||||
Short-Term Investments (e) | 30,006,088 | | | 30,006,088 | ||||||||||||
Total | $ | 584,713,836 | $ | | $ | | $ | 584,713,836 |
(e) | See Investment Portfolio for additional detailed categorizations. |
The accompanying notes are an integral part of the financial statements.
DWS CROCI® U.S. Fund | | | 13 |
Statement of Assets and Liabilities
as of March 31, 2020 (Unaudited) | ||||
Assets |
| |||
Investments in non-affiliated securities, at value (cost $758,785,214) including $13,877,209 of securities loaned | $ | 554,707,748 | ||
Investment in DWS Government & Agency Securities Portfolio (cost $14,343,595)* |
14,343,595 | |||
Investment in DWS Central Cash Management Government Fund (cost $15,662,493) |
15,662,493 | |||
Receivable for Fund shares sold | 23,608 | |||
Dividends receivable | 1,687,031 | |||
Interest receivable | 6,545 | |||
Other assets | 76,424 | |||
Total assets | 586,507,444 | |||
Liabilities | ||||
Payable upon return of securities loaned | 14,343,595 | |||
Payable for Fund shares redeemed | 384,908 | |||
Accrued Management fee | 222,060 | |||
Accrued Trustees fees | 10,280 | |||
Other accrued expenses and payables | 362,952 | |||
Total liabilities | 15,323,795 | |||
Net assets, at value | $ | 571,183,649 | ||
Net Assets Consist of |
| |||
Distributable earnings (loss) | (183,722,394 | ) | ||
Paid-in capital | 754,906,043 | |||
Net assets, at value | $ | 571,183,649 |
* | Represents collateral on securities loaned. |
The accompanying notes are an integral part of the financial statements.
14 | | | DWS CROCI® U.S. Fund |
Statement of Assets and Liabilities as of March 31, 2020 (Unaudited) (continued) |
Net Asset Value | ||||
Class A |
||||
Net Asset Value and redemption price per share ($92,265,460 ÷ 11,019,477 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized) |
$ | 8.37 | ||
Maximum offering price per share (100 ÷ 94.25 of $8.37) | $ | 8.88 | ||
Class T |
||||
Net Asset Value and redemption price per share ($8,807 ÷ 1,051 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized) |
$ | 8.38 | ||
Maximum offering price per share (100 ÷ 97.5 of $8.38) | $ | 8.59 | ||
Class C |
||||
Net Asset Value, offering and redemption price (subject to contingent deferred sales charge) per share ($2,222,917 ÷ 268,085 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized) |
$ | 8.29 | ||
Class R |
||||
Net Asset Value, offering and redemption price per share ($1,106,922 ÷ 132,232 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized) |
$ | 8.37 | ||
Class R6 |
||||
Net Asset Value, offering and redemption price per share ($108,263 ÷ 12,923 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized) |
$ | 8.38 | ||
Class S |
||||
Net Asset Value, offering and redemption price per share ($469,924,942 ÷ 56,102,616 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized) |
$ | 8.38 | ||
Institutional Class |
| |||
Net Asset Value, offering and redemption price per share ($5,546,338 ÷ 662,525 outstanding shares of beneficial interest, $.01 par value, unlimited number of shares authorized) |
$ | 8.37 |
The accompanying notes are an integral part of the financial statements.
DWS CROCI® U.S. Fund | | | 15 |
for the six months ended March 31, 2020 (Unaudited) | ||||
Investment Income | ||||
Income: |
||||
Dividends | $ | 11,742,588 | ||
Income distributions DWS Central Cash Management Government Fund |
40,620 | |||
Securities lending income, net of borrower rebates | 3,319 | |||
Total income | 11,786,527 | |||
Expenses: | ||||
Management fee | 1,713,957 | |||
Administration fee | 401,707 | |||
Services to shareholders | 459,928 | |||
Distribution and service fees | 179,313 | |||
Custodian fee | 5,430 | |||
Professional fees | 41,093 | |||
Reports to shareholders | 34,557 | |||
Registration fees | 35,213 | |||
Trustees fees and expenses | 16,023 | |||
Other | 32,237 | |||
Total expenses before expense reductions | 2,919,458 | |||
Expense reductions | (2,275) | |||
Total expenses after expense reductions | 2,917,183 | |||
Net investment income | 8,869,344 | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) from investments | 15,862,121 | |||
Change in net unrealized appreciation (depreciation) on investments | (205,558,744) | |||
Net gain (loss) | (189,696,623) | |||
Net increase (decrease) in net assets resulting from operations | $ | (180,827,279) |
The accompanying notes are an integral part of the financial statements.
16 | | | DWS CROCI® U.S. Fund |
Statements of Changes in Net Assets
Increase (Decrease) in Net Assets | Six Months Ended March 31, 2020 (Unaudited) |
Year Ended September 30, 2019 |
||||||
Operations: | ||||||||
Net investment income (loss) | $ | 8,869,344 | $ | 17,251,625 | ||||
Net realized gain (loss) | 15,862,121 | 34,394,069 | ||||||
Change in net unrealized appreciation (depreciation) | (205,558,744 | ) | (31,491,425 | ) | ||||
Net increase (decrease) in net assets resulting from operations | (180,827,279 | ) | 20,154,269 | |||||
Distributions to shareholders: | ||||||||
Class A |
(7,738,657 | ) | (4,557,950 | ) | ||||
Class T |
(712 | ) | (372 | ) | ||||
Class C |
(181,194 | ) | (139,374 | ) | ||||
Class R |
(91,003 | ) | (57,611 | ) | ||||
Class R6 |
(9,295 | ) | (5,000 | ) | ||||
Class S |
(41,300,035 | ) | (24,389,767 | ) | ||||
Institutional Class |
(991,341 | ) | (285,160 | ) | ||||
Total distributions | (50,312,237 | ) | (29,435,234 | ) | ||||
Fund share transactions: | ||||||||
Proceeds from shares sold | 21,163,545 | 24,270,750 | ||||||
Reinvestment of distributions | 47,826,730 | 28,053,132 | ||||||
Payments for shares redeemed | (71,439,863 | ) | (107,842,945 | ) | ||||
Net increase (decrease) in net assets from Fund share transactions | (2,449,588 | ) | (55,519,063 | ) | ||||
Increase (decrease) in net assets | (233,589,104 | ) | (64,800,028 | ) | ||||
Net assets at beginning of period | 804,772,753 | 869,572,781 | ||||||
Net assets at end of period | 571,183,649 | $ | 804,772,753 |
The accompanying notes are an integral part of the financial statements.
DWS CROCI® U.S. Fund | | | 17 |
Six Months Ended 3/31/20 |
Years Ended September 30, | Period Ended |
||||||||||||||||||||||||
Class A | (Unaudited) | 2019 | 2018 | 2017 | 2016 | 9/30/15a | ||||||||||||||||||||
Selected Per Share Data |
|
|||||||||||||||||||||||||
Net asset value, beginning of period | $11.70 | $11.83 | $11.21 | $9.51 | $8.65 | $10.00 | ||||||||||||||||||||
Income (loss) from investment operations: | ||||||||||||||||||||||||||
Net investment income (loss)b |
.11 | .21 | .17 | .16 | .15 | .06 | ||||||||||||||||||||
Net realized and unrealized gain (loss) |
(2.74 | ) | .04 | .69 | 1.55 | .81 | (1.41 | ) | ||||||||||||||||||
Total from investment operations |
(2.63 | ) | .25 | .86 | 1.71 | .96 | (1.35 | ) | ||||||||||||||||||
Less distributions from: | ||||||||||||||||||||||||||
Net investment income |
(.19 | ) | (.25 | ) | (.11 | ) | (.01 | ) | (.10 | ) | | |||||||||||||||
Net realized gains |
(.51 | ) | (.13 | ) | (.13 | ) | | | | |||||||||||||||||
Total distributions |
(.70 | ) | (.38 | ) | (.24 | ) | (.01 | ) | (.10 | ) | | |||||||||||||||
Net asset value, end of period |
$8.37 | $11.70 | $11.83 | $11.21 | $9.51 | $8.65 | ||||||||||||||||||||
Total Return (%)c | (24.33 | )** | 2.61 | 7.87 | 17.94 | 11.26 | d | (13.50 | )d** | |||||||||||||||||
Ratios to Average Net Assets and Supplemental Data |
| |||||||||||||||||||||||||
Net assets, end of period ($ millions) | 92 | 132 | 147 | 154 | .39 | .19 | ||||||||||||||||||||
Ratio of expenses before expense reductions (%) | 1.00 | * | .99 | 1.01 | .96 | 3.35 | 4.62 | * | ||||||||||||||||||
Ratio of expenses after expense reductions (%) |
1.00 | * | .99 | 1.01 | .96 | 1.06 | 1.06 | * | ||||||||||||||||||
Ratio of net investment income (loss) (%) | 1.92 | * | 1.88 | 1.48 | 1.50 | 1.68 | 1.45 | * | ||||||||||||||||||
Portfolio turnover rate (%) | 56 | ** | 95 | 98 | 100 | 98 | 29 | ** |
a | For the period from April 13, 2015 (commencement of operations) to September 30, 2015. |
b | Based on average shares outstanding during the period. |
c | Total return does not reflect the effect of any sales charges. |
d | Total return would have been lower had certain expenses not been reduced. |
* | Annualized |
** | Not annualized |
The accompanying notes are an integral part of the financial statements.
18 | | | DWS CROCI® U.S. Fund |
Six Months Ended 3/31/20 |
Years Ended September 30, |
Period Ended |
||||||||||||||||
Class T | (Unaudited) | 2019 | 2018 | 9/30/17a | ||||||||||||||
Selected Per Share Data |
| |||||||||||||||||
Net asset value, beginning of period |
$11.71 | $11.85 | $11.21 | $10.68 | ||||||||||||||
Income (loss) from investment operations: | ||||||||||||||||||
Net investment income (loss)b |
.12 | .22 | .18 | .05 | ||||||||||||||
Net realized and unrealized gain (loss) |
(2.74 | ) | .03 | .69 | .48 | |||||||||||||
Total from investment operations |
(2.62 | ) | .25 | .87 | .53 | |||||||||||||
Less distributions from: | ||||||||||||||||||
Net investment income |
(.20 | ) | (.26 | ) | (.10 | ) | | |||||||||||
Net realized gains |
(.51 | ) | (.13 | ) | (.13 | ) | | |||||||||||
Total distributions |
(.71 | ) | (.39 | ) | (.23 | ) | | |||||||||||
Net asset value, end of period |
$8.38 | $11.71 | $11.85 | $11.21 | ||||||||||||||
Total Return (%)c | (24.25 | )** | 2.70 | 7.87 | 4.96 | d** | ||||||||||||
Ratios to Average Net Assets and Supplemental Data |
|
|||||||||||||||||
Net assets, end of period ($ thousands) | 9 | 12 | 11 | 10 | ||||||||||||||
Ratio of expenses before expense reductions (%) | .90 | * | .92 | .93 | 1.05 | * | ||||||||||||
Ratio of expenses after expense reductions (%) | .90 | * | .92 | .93 | 1.04 | * | ||||||||||||
Ratio of net investment income (loss) (%) | 2.03 | * | 1.97 | 1.57 | 1.53 | * | ||||||||||||
Portfolio turnover rate (%) | 56 | ** | 95 | 98 | 100 | e |
a | For the period from June 5, 2017 (commencement of operations) to September 30, 2017. |
b | Based on average shares outstanding during the period. |
c | Total return does not reflect the effect of any sales charges. |
d | Total return would have been lower had certain expenses not been reduced. |
e | Represents the Funds portfolio turnover rate for the year ended September 30, 2017. |
* | Annualized |
** | Not annualized |
The accompanying notes are an integral part of the financial statements.
DWS CROCI® U.S. Fund | | | 19 |
Six Months Ended 3/31/20 |
Years Ended September 30, | Period Ended |
||||||||||||||||||||||||
Class C | (Unaudited) | 2019 | 2018 | 2017 | 2016 | 9/30/15a | ||||||||||||||||||||
Selected Per Share Data |
| |||||||||||||||||||||||||
Net asset value, beginning of period | $11.55 | $11.68 | $11.06 | $9.45 | $8.61 | $10.00 | ||||||||||||||||||||
Income (loss) from investment operations: | ||||||||||||||||||||||||||
Net investment income (loss)b |
.06 | .12 | .08 | .08 | .09 | .03 | ||||||||||||||||||||
Net realized and unrealized gain (loss) |
(2.71 | ) | .05 | .69 | 1.53 | .81 | (1.42 | ) | ||||||||||||||||||
Total from investment operations |
(2.65 | ) | .17 | .77 | 1.61 | .90 | (1.39 | ) | ||||||||||||||||||
Less distributions from: | ||||||||||||||||||||||||||
Net investment income |
(.10 | ) | (.17 | ) | (.02 | ) | | (.06 | ) | | ||||||||||||||||
Net realized gains |
(.51 | ) | (.13 | ) | (.13 | ) | | | | |||||||||||||||||
Total distributions |
(.61 | ) | (.30 | ) | (.15 | ) | | (.06 | ) | | ||||||||||||||||
Net asset value, end of period |
$8.29 | $11.55 | $11.68 | $11.06 | $9.45 | $8.61 | ||||||||||||||||||||
Total Return (%)c | (24.62 | )d** | 1.90 | 7.05 | 17.04 | 10.47 | d | (13.90 | )d** | |||||||||||||||||
Ratios to Average Net Assets and Supplemental Data |
| |||||||||||||||||||||||||
Net assets, end of period ($ millions) | 2 | 4 | 6 | 16 | 1 | .12 | ||||||||||||||||||||
Ratio of expenses before expense reductions (%) | 1.81 | * | 1.73 | 1.75 | 1.72 | 4.09 | 5.38 | * | ||||||||||||||||||
Ratio of expenses after expense reductions (%) | 1.77 | * | 1.73 | 1.75 | 1.72 | 1.81 | 1.81 | * | ||||||||||||||||||
Ratio of net investment income (loss) (%) | 1.12 | * | 1.11 | .70 | .74 | .95 | .71 | * | ||||||||||||||||||
Portfolio turnover rate (%) | 56 | ** | 95 | 98 | 100 | 98 | 29 | ** |
a | For the period from April 13, 2015 (commencement of operations) to September 30, 2015. |
b | Based on average shares outstanding during the period. |
c | Total return does not reflect the effect of any sales charges. |
d | Total return would have been lower had certain expenses not been reduced. |
* | Annualized |
** | Not annualized |
The accompanying notes are an integral part of the financial statements.
20 | | | DWS CROCI® U.S. Fund |
Six Months Ended 3/31/20 |
Years Ended September 30, |
Period Ended |
||||||||||||||||
Class R | (Unaudited) | 2019 | 2018 | 9/30/17a | ||||||||||||||
Selected Per Share Data |
| |||||||||||||||||
Net asset value, beginning of period |
$11.68 | $11.82 | $11.19 | $9.67 | ||||||||||||||
Income (loss) from investment operations: | ||||||||||||||||||
Net investment income (loss)b |
.10 | .17 | .14 | .10 | ||||||||||||||
Net realized and unrealized gain (loss) |
(2.74 | ) | .04 | .70 | 1.42 | |||||||||||||
Total from investment operations |
(2.64 | ) | .21 | .84 | 1.52 | |||||||||||||
Less distributions from: | ||||||||||||||||||
Net investment income |
(.16 | ) | (.22 | ) | (.08 | ) | | |||||||||||
Net realized gains |
(.51 | ) | (.13 | ) | (.13 | ) | | |||||||||||
Total distributions |
(.67 | ) | (.35 | ) | (.21 | ) | | |||||||||||
Net asset value, end of period |
$8.37 | $11.68 | $11.82 | $11.19 | ||||||||||||||
Total Return (%) | (24.43 | )c** | 2.30 | c | 7.54 | c | 15.72 | ** | ||||||||||
Ratios to Average Net Assets and Supplemental Data |
| |||||||||||||||||
Net assets, end of period ($ millions) | 1 | 2 | 2 | 2 | ||||||||||||||
Ratio of expenses before expense reduction (%) | 1.34 | * | 1.34 | 1.39 | 1.27 | * | ||||||||||||
Ratio of expenses after expense reduction (%) | 1.29 | * | 1.29 | 1.29 | 1.27 | * | ||||||||||||
Ratio of net investment income (loss) (%) | 1.65 | * | 1.57 | 1.20 | 1.19 | * | ||||||||||||
Portfolio turnover rate (%) | 56 | ** | 95 | 98 | 100 | d |
a | For the period from December 9, 2016 (commencement of operations) to September 30, 2017. |
b | Based on average shares outstanding during the period. |
c | Total return would have been lower had certain expenses not been reduced. |
d | Represents the Funds portfolio turnover rate for the year ended September 30, 2017. |
* | Annualized |
** | Not annualized |
The accompanying notes are an integral part of the financial statements.
DWS CROCI® U.S. Fund | | | 21 |
Six Months Ended 3/31/20 |
Years Ended September 30, | Period Ended |
||||||||||||||||||||||||
Class R6 | (Unaudited) | 2019 | 2018 | 2017 | 2016 | 9/30/15a | ||||||||||||||||||||
Selected Per Share Data |
|
|||||||||||||||||||||||||
Net asset value, beginning of period | $11.73 | $11.87 | $11.24 | $9.53 | $8.66 | $10.00 | ||||||||||||||||||||
Income (loss) from investment operations: | ||||||||||||||||||||||||||
Net investment income (loss)b |
.14 | .26 | .22 | .20 | .18 | .08 | ||||||||||||||||||||
Net realized and unrealized gain (loss) |
(2.73 | ) | .02 | .70 | 1.54 | .81 | (1.42 | ) | ||||||||||||||||||
Total from investment operations |
(2.59 | ) | .28 | .92 | 1.74 | .99 | (1.34 | ) | ||||||||||||||||||
Less distributions from: | ||||||||||||||||||||||||||
Net investment income |
(.25 | ) | (.29 | ) | (.16 | ) | (.03 | ) | (.12 | ) | | |||||||||||||||
Net realized gains |
(.51 | ) | (.13 | ) | (.13 | ) | | | | |||||||||||||||||
Total distributions |
(.76 | ) | (.42 | ) | (.29 | ) | (.03 | ) | (.12 | ) | | |||||||||||||||
Net asset value, end of period |
$8.38 | $11.73 | $11.87 | $11.24 | $9.53 | $8.66 | ||||||||||||||||||||
Total Return (%)c | (24.12 | )** | 3.07 | 8.23 | 18.30 | 11.57 | (13.40 | )** | ||||||||||||||||||
Ratios to Average Net Assets and Supplemental Data |
| |||||||||||||||||||||||||
Net assets, end of period ($ thousands) | 108 | 143 | 138 | 128 | 97 | 87 | ||||||||||||||||||||
Ratio of expenses before expense reductions (%) | .63 | * | .64 | .61 | .62 | 3.07 | 4.36 | * | ||||||||||||||||||
Ratio of expenses after expense reductions (%) |
.60 | * | .59 | .59 | .61 | .81 | .81 | * | ||||||||||||||||||
Ratio of net investment income (loss) (%) | 2.33 | * | 2.30 | 1.91 | 1.96 | 1.95 | 1.72 | * | ||||||||||||||||||
Portfolio turnover rate (%) | 56 | ** | 95 | 98 | 100 | 98 | 29 | ** |
a | For the period from April 13, 2015 (commencement of operations) to September 30, 2015. |
b | Based on average shares outstanding during the period. |
c | Total return would have been lower had certain expenses not been reduced. |
* | Annualized |
** | Not annualized |
The accompanying notes are an integral part of the financial statements.
22 | | | DWS CROCI® U.S. Fund |
Six Months Ended 3/31/20 |
Years Ended September 30, | Period Ended |
||||||||||||||||||||||||
Class S | (Unaudited) | 2019 | 2018 | 2017 | 2016 | 9/30/15a | ||||||||||||||||||||
Selected Per Share Data |
|
|||||||||||||||||||||||||
Net asset value, beginning of period | $11.73 | $11.86 | $11.23 | $9.51 | $8.65 | $10.00 | ||||||||||||||||||||
Income (loss) from investment operations: | ||||||||||||||||||||||||||
Net investment income (loss)b |
.13 | .25 | .21 | .19 | .16 | .08 | ||||||||||||||||||||
Net realized and unrealized gain (loss) |
(2.73 | ) | .03 | .70 | 1.55 | .82 | (1.43 | ) | ||||||||||||||||||
Total from investment operations |
(2.60 | ) | .28 | .91 | 1.74 | .98 | (1.35 | ) | ||||||||||||||||||
Less distributions from: | ||||||||||||||||||||||||||
Net investment income |
(.24 | ) | (.28 | ) | (.15 | ) | (.02 | ) | (.12 | ) | | |||||||||||||||
Net realized gains |
(.51 | ) | (.13 | ) | (.13 | ) | | | | |||||||||||||||||
Total distributions |
(.75 | ) | (.41 | ) | (.28 | ) | (.02 | ) | (.12 | ) | | |||||||||||||||
Net asset value, end of period |
$8.38 | $11.73 | $11.86 | $11.23 | $9.51 | $8.65 | ||||||||||||||||||||
Total Return (%) | (24.12 | )** | 2.98 | 8.17 | 18.33 | 11.44 | c | (13.50 | )c** | |||||||||||||||||
Ratios to Average Net Assets and Supplemental Data |
| |||||||||||||||||||||||||
Net assets, end of period ($ millions) | 470 | 660 | 706 | 718 | .55 | .11 | ||||||||||||||||||||
Ratio of expenses before expense reductions (%) | .66 | * | .67 | .67 | .67 | 3.22 | 4.37 | * | ||||||||||||||||||
Ratio of expenses after expense reductions (%) |
.66 | * | .67 | .67 | .67 | .91 | .84 | * | ||||||||||||||||||
Ratio of net investment income (loss) (%) | 2.26 | * | 2.21 | 1.83 | 1.79 | 1.81 | 1.71 | * | ||||||||||||||||||
Portfolio turnover rate (%) | 56 | ** | 95 | 98 | 100 | 98 | 29 | ** |
a | For the period from April 13, 2015 (commencement of operations) to September 30, 2015. |
b | Based on average shares outstanding during the period. |
c | Total return would have been lower had certain expenses not been reduced. |
* | Annualized |
** | Not annualized |
The accompanying notes are an integral part of the financial statements.
DWS CROCI® U.S. Fund | | | 23 |
Six Months Ended 3/31/20 |
Years Ended September 30, | Period Ended |
||||||||||||||||||||||||
Institutional Class | (Unaudited) | 2019 | 2018 | 2017 | 2016 | 9/30/15a | ||||||||||||||||||||
Selected Per Share Data |
|
|||||||||||||||||||||||||
Net asset value, beginning of period | $11.72 | $11.86 | $11.23 | $9.53 | $8.66 | $10.00 | ||||||||||||||||||||
Income (loss) from investment operations: | ||||||||||||||||||||||||||
Net investment income (loss)b |
.13 | .24 | .21 | .19 | .18 | .08 | ||||||||||||||||||||
Net realized and unrealized gain (loss) |
(2.74 | ) | .03 | .70 | 1.54 | .81 | (1.42 | ) | ||||||||||||||||||
Total from investment operations |
(2.61 | ) | .27 | .91 | 1.73 | .99 | (1.34 | ) | ||||||||||||||||||
Less distributions from: | ||||||||||||||||||||||||||
Net investment income |
(.23 | ) | (.28 | ) | (.15 | ) | (.03 | ) | (.12 | ) | | |||||||||||||||
Net realized gains |
(.51 | ) | (.13 | ) | (.13 | ) | | | | |||||||||||||||||
Total distributions |
(.74 | ) | (.41 | ) | (.28 | ) | (.03 | ) | (.12 | ) | | |||||||||||||||
Net asset value, end of period |
$8.37 | $11.72 | $11.86 | $11.23 | $9.53 | $8.66 | ||||||||||||||||||||
Total Return (%) | (24.16 | )c** | 2.88 | c | 8.18 | 18.20 | 11.57 | c | (13.40 | )c** | ||||||||||||||||
Ratios to Average Net Assets and Supplemental Data |
| |||||||||||||||||||||||||
Net assets, end of period ($ millions) | 6 | 7 | 9 | 7 | 5 | 4 | ||||||||||||||||||||
Ratio of expenses before expense reductions (%) | .69 | * | .71 | .68 | .66 | 3.05 | 4.34 | * | ||||||||||||||||||
Ratio of expenses after expense reductions (%) |
.67 | * | .69 | .68 | .66 | .81 | .81 | * | ||||||||||||||||||
Ratio of net investment income (loss) (%) | 2.19 | * | 2.14 | 1.84 | 1.87 | 1.95 | 1.72 | * | ||||||||||||||||||
Portfolio turnover rate (%) | 56 | ** | 95 | 98 | 100 | 98 | 29 | ** |
a | For the period from April 13, 2015 (commencement of operations) to September 30, 2015. |
b | Based on average shares outstanding during the period. |
c | Total return would have been lower had certain expenses not been reduced. |
* | Annualized |
** | Not annualized |
The accompanying notes are an integral part of the financial statements.
24 | | | DWS CROCI® U.S. Fund |
Notes to Financial Statements | (Unaudited) |
A. Organization and Significant Accounting Policies
DWS CROCI® U.S. Fund (the Fund) is a diversified series of Deutsche DWS Investment Trust (the Trust), which is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust.
The Fund offers multiple classes of shares which provide investors with different purchase options. Class A shares are subject to an initial sales charge. Class T shares are subject to an initial sales charge and are only available through certain financial intermediaries. Class T shares are closed to new purchases, except in connection with the reinvestment of dividends or other distributions. Class C shares are not subject to an initial sales charge but are subject to higher ongoing expenses than Class A shares and a contingent deferred sales charge payable upon certain redemptions within one year of purchase. Class C shares automatically convert to Class A shares in the same fund after 10 years, provided that the fund or the financial intermediary through which the shareholder purchased the Class C shares has records verifying that the Class C shares have been held for at least 10 years. Class R and Class R6 shares are not subject to initial or contingent deferred sales charges and are generally available only to certain retirement plans. Class S shares are not subject to initial or contingent deferred sales charges and are only available to a limited group of investors. Institutional Class shares are not subject to initial or contingent deferred sales charges and are generally available only to qualified institutions.
Investment income, realized and unrealized gains and losses, and certain fund-level expenses and expense reductions, if any, are borne pro rata on the basis of relative net assets by the holders of all classes of shares, except that each class bears certain expenses unique to that class such as distribution and service fees, services to shareholders and certain other class-specific expenses. Differences in class-level expenses may result in payment of different per share dividends by class. All shares of the Fund have equal rights with respect to voting subject to class-specific arrangements.
The Funds financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) which require the use of management estimates. Actual results could differ from those estimates. The Fund qualifies as an investment company under Topic 946 of Accounting Standards Codification of U.S. GAAP. The policies described below are followed consistently by the Fund in the preparation of its financial statements.
DWS CROCI® U.S. Fund | | | 25 |
Security Valuation. Investments are stated at value determined as of the close of regular trading on the New York Stock Exchange on each day the exchange is open for trading.
Various inputs are used in determining the value of the Funds investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Funds own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.
Equity securities are valued at the most recent sale price or official closing price reported on the exchange (U.S. or foreign) or over-the-counter market on which they trade. Securities for which no sales are reported are valued at the calculated mean between the most recent bid and asked quotations on the relevant market or, if a mean cannot be determined, at the most recent bid quotation. Equity securities are generally categorized as Level 1.
Investments in open-end investment companies are valued at their net asset value each business day and are categorized as Level 1.
Securities and other assets for which market quotations are not readily available or for which the above valuation procedures are deemed not to reflect fair value are valued in a manner that is intended to reflect their fair value as determined in accordance with procedures approved by the Board and are generally categorized as Level 3. In accordance with the Funds valuation procedures, factors considered in determining value may include, but are not limited to, the type of the security; the size of the holding; the initial cost of the security; the existence of any contractual restrictions on the securitys disposition; the price and extent of public trading in similar securities of the issuer or of comparable companies; quotations or evaluated prices from broker-dealers and/or pricing services; information obtained from the issuer, analysts, and/or the appropriate stock exchange (for exchange-traded securities); an analysis of the companys or issuers financial statements; an evaluation of the forces that influence the issuer and the market(s) in which the security is purchased and sold; and with respect to debt securities, the maturity, coupon, creditworthiness, currency denomination and the movement of the market in which the security is normally traded. The value determined under these procedures may differ from published values for the same securities.
Disclosure about the classification of fair value measurements is included in a table following the Funds Investment Portfolio.
26 | | | DWS CROCI® U.S. Fund |
Securities Lending. Brown Brothers Harriman & Co. as lending agent, lends securities of the Fund to certain financial institutions under the terms of its securities lending agreement. During the term of the loans, the Fund continues to receive interest and dividends generated by the securities and to participate in any changes in their market value. The Fund requires the borrowers of the securities to maintain collateral with the Fund consisting of either cash and/or U.S. Treasury Securities having a value at least equal to the value of the securities loaned. When the collateral falls below specified amounts, the lending agent will use its best effort to obtain additional collateral on the next business day to meet required amounts under the securities lending agreement. During the six months ended March 31, 2020, the Fund invested the cash collateral into a joint trading account in DWS Government & Agency Securities Portfolio, an affiliated money market fund managed by DWS Investment Management Americas, Inc. DWS Investment Management Americas, Inc. receives a management/administration fee (0.12% annualized effective rate as of March 31, 2020) on the cash collateral invested in DWS Government & Agency Securities Portfolio. The Fund receives compensation for lending its securities either in the form of fees or by earning interest on invested cash collateral net of borrower rebates and fees paid to a lending agent. Either the Fund or the borrower may terminate the loan at any time, and the borrower, after notice, is required to return borrowed securities within a standard time period. There may be risks of delay and costs in recovery of securities or even loss of rights in the collateral should the borrower of the securities fail financially. If the Fund is not able to recover securities lent, the Fund may sell the collateral and purchase a replacement investment in the market, incurring the risk that the value of the replacement security is greater than the value of the collateral. The Fund is also subject to all investment risks associated with the reinvestment of any cash collateral received, including, but not limited to, interest rate, credit and liquidity risk associated with such investments.
As of March 31, 2020, the Fund had securities on loan, which were classified as common stocks in the Investment Portfolio. The value of the related collateral exceeded the value of the securities loaned at period end. As of period end, the remaining contractual maturity of the collateral agreements was overnight and continuous.
Federal Income Taxes. The Funds policy is to comply with the requirements of the Internal Revenue Code, as amended, which are applicable to regulated investment companies, and to distribute all of its taxable income to its shareholders.
At March 31, 2020, the aggregate cost of investments for federal income tax purposes was $790,300,175. The net unrealized depreciation for all investments based on tax cost was $205,586,339. This consisted of aggregate gross unrealized appreciation for all investments in which there
DWS CROCI® U.S. Fund | | | 27 |
was an excess of value over tax cost of $17,244,894 and aggregate gross unrealized depreciation for all investments in which there was an excess of tax cost over value of $222,831,233.
The Fund has reviewed the tax positions for the open tax years as of September 30, 2019 and has determined that no provision for income tax and/or uncertain tax positions is required in the Funds financial statements. The Funds federal tax returns for the prior three fiscal years remain open subject to examination by the Internal Revenue Service.
Distribution of Income and Gains. Distributions from net investment income of the Fund, if any, are declared and distributed to shareholders annually. Net realized gains from investment transactions, in excess of available capital loss carryforwards, would be taxable to the Fund if not distributed, and, therefore, will be distributed to shareholders at least annually. The Fund may also make additional distributions for tax purposes if necessary.
The timing and characterization of certain income and capital gain distributions are determined annually in accordance with federal tax regulations which may differ from accounting principles generally accepted in the United States of America. These differences primarily relate to certain securities sold at a loss. As a result, net investment income (loss) and net realized gain (loss) on investment transactions for a reporting period may differ significantly from distributions during such period. Accordingly, the Fund may periodically make reclassifications among certain of its capital accounts without impacting the net asset value of the Fund.
The tax character of current year distributions will be determined at the end of the current fiscal year.
Expenses. Expenses of the Trust arising in connection with a specific fund are allocated to that fund. Other Trust expenses which cannot be directly attributed to a fund are apportioned among the funds in the Trust based upon the relative net assets or other appropriate measures.
Contingencies. In the normal course of business, the Fund may enter into contracts with service providers that contain general indemnification clauses. The Funds maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet been made. However, based on experience, the Fund expects the risk of loss to be remote.
Other. Investment transactions are accounted for on a trade date plus one basis for daily net asset value calculations. However, for financial reporting purposes, investment transactions are reported on trade date. Interest income is recorded on the accrual basis. Dividend income is recorded on the ex-dividend date net of foreign withholding taxes.
28 | | | DWS CROCI® U.S. Fund |
Realized gains and losses from investment transactions are recorded on an identified cost basis. Proceeds from litigation payments, if any, are included in net realized gain (loss) from investments.
B. Purchases and Sales of Securities
During the six months ended March 31, 2020, purchases and sales of investment securities (excluding short-term investments) aggregated $437,953,388 and $494,038,453, respectively.
C. Related Parties
Management Agreement. Under the Investment Management Agreement with DWS Investment Management Americas, Inc. (DIMA or the Advisor), an indirect, wholly owned subsidiary of DWS Group GmbH & Co. KGaA (DWS Group), the Advisor directs the investments of the Fund in accordance with its investment objectives, policies and restrictions. The Advisor determines the securities, instruments and other contracts relating to investments to be purchased, sold or entered into by the Fund.
Under the Investment Management Agreement with the Advisor, the Fund pays a monthly management fee based on the average daily net assets of the Fund, computed and accrued daily and payable monthly, at the following annual rates:
First $1.5 billion of the Funds average daily net assets | .425% | |||
Next $500 million of such net assets | .400% | |||
Next $1.0 billion of such net assets | .375% | |||
Next $1.0 billion of such net assets | .350% | |||
Next $1.0 billion of such net assets | .325% | |||
Over $5.0 billion of such net assets | .300% |
Accordingly, for the six months ended March 31, 2020, the fee pursuant to the Investment Management Agreement was equivalent to an annualized rate (exclusive of any applicable waivers/reimbursements) of 0.425% of the Funds average daily net assets.
For the period from October 1, 2019 through January 31, 2020 (through November 14, 2019 for Institutional Class shares), the Advisor has contractually agreed to waive its fees and/or reimburse certain operating expenses of the Fund to the extent necessary to maintain the total annual operating expenses (excluding certain expenses such as extraordinary expenses, taxes, brokerage and interest) of each class as follows:
DWS CROCI® U.S. Fund | | | 29 |
Class A | 1.04% | |||
Class T | 1.04% | |||
Class C | 1.76% | |||
Class R | 1.29% | |||
Class R6 | .59% | |||
Class S | .69% | |||
Institutional Class | .69% |
Effective February 1, 2020 through September 30, 2020 (through January 31, 2021 for Class R) and effective November 15, 2019 through January 31, 2021 for Institutional Class shares, the Advisor has contractually agreed to waive its fees and/or reimburse certain operating expenses of the Fund to the extent necessary to maintain the total annual operating expenses (excluding certain expenses such as extraordinary expenses, taxes, brokerage and interest) of each class as follows:
Class A | 1.05% | |||
Class T | 1.05% | |||
Class C | 1.80% | |||
Class R | 1.30% | |||
Class R6 | .80% | |||
Class S | .80% | |||
Institutional Class | .67% |
For the six months ended March 31, 2020, fees waived and/or expenses reimbursed for certain classes are as follows:
Class C | $ | 613 | ||
Class R | 388 | |||
Class R6 | 22 | |||
Institutional Class | 1,252 | |||
$ | 2,275 |
Administration Fee. Pursuant to an Administrative Services Agreement, DIMA provides most administrative services to the Fund. Prior to March 1, 2020, for all services provided under the Administrative Services Agreement, the Fund paid the Advisor an annual fee (Administration Fee) of 0.10% of the Funds average daily net assets, computed and accrued daily and payable monthly. Effective March 1, 2020, for all services provided under the Administrative Services Agreement, the Fund pays the Advisor an annual Administration Fee of 0.097% of the Funds average daily net assets, computed and accrued daily and payable monthly. For the six months ended March 31, 2020, the Administration Fee was $401,707, of which $50,992 is unpaid.
Service Provider Fees. DWS Service Company (DSC), an affiliate of the Advisor, is the transfer agent, dividend-paying agent and shareholder
30 | | | DWS CROCI® U.S. Fund |
service agent of the Fund. Pursuant to a sub-transfer agency agreement between DSC and DST Systems, Inc. (DST), DSC has delegated certain transfer agent, dividend-paying agent and shareholder service agent functions to DST. DSC compensates DST out of the shareholder servicing fee it receives from the Fund. For the six months ended March 31, 2020, the amounts charged to the Fund by DSC were as follows:
Services to Shareholders | Total Aggregated |
Unpaid at March 31, 2020 |
||||||
Class A | $ | 28,254 | $ | 10,271 | ||||
Class T | 11 | 3 | ||||||
Class C | 1,038 | 436 | ||||||
Class R | 56 | 19 | ||||||
Class R6 | 37 | 11 | ||||||
Class S | 146,739 | 51,464 | ||||||
Institutional Class | 396 | 168 | ||||||
$ | 176,531 | $ | 62,372 |
In addition, for the six months ended March 31, 2020, the amounts charged to the Fund for recordkeeping and other administrative services provided by unaffiliated third parties, included in the Statement of Operations under Services to shareholders, were as follows:
Sub-Recordkeeping | Total Aggregated |
|||
Class A | $ | 82,872 | ||
Class C | 2,871 | |||
Class R | 2,076 | |||
Class S | 119,607 | |||
Institutional Class | 6,372 | |||
$ | 213,798 |
Distribution and Service Fees. Under the Funds Class C and Class R 12b-1 plans, DWS Distributors, Inc. (DDI), an affiliate of the Advisor, receives a fee (Distribution Fee) of 0.75% and 0.25% of the average daily net assets of Class C and Class R shares, respectively. In accordance with the Funds Underwriting and Distribution Service Agreement, DDI enters into related selling group agreements with various firms at various rates for sales of Class C shares. For the six months ended March 31, 2020, the Distribution Fee was as follows:
Distribution Fee | Total Aggregated |
Unpaid at March 31, 2020 |
||||||
Class C | $ | 12,908 | $ | 1,551 | ||||
Class R | 2,068 | 267 | ||||||
$ | 14,976 | $ | 1,818 |
DWS CROCI® U.S. Fund | | | 31 |
In addition, DDI provides information and administrative services for a fee (Service Fee) to Class A, T, C and R shareholders at an annual rate of up to 0.25% of average daily net assets for each such class. DDI in turn has various agreements with financial services firms that provide these services and pays these fees based upon the assets of shareholder accounts the firms service. For the six months ended March 31, 2020, the Service Fee was as follows:
Service Fee | Total Aggregated |
Unpaid at March 31, 2020 |
Annualized Rate |
|||||||||
Class A | $ | 158,016 | $ | 45,975 | .24 | % | ||||||
Class T | 9 | 9 | .15 | % | ||||||||
Class C | 4,247 | 1,445 | .25 | % | ||||||||
Class R | 2,065 | 690 | .25 | % | ||||||||
$ | 164,337 | $ | 48,119 |
Underwriting Agreement and Contingent Deferred Sales Charge. DDI is the principal underwriter for the Fund. Underwriting commissions paid in connection with the distribution of Class A shares for the six months ended March 31, 2020 aggregated $1,178.
In addition, DDI receives any contingent deferred sales charge (CDSC) from Class C share redemptions occurring within one year of purchase. There is no such charge upon redemption of any share appreciation or reinvested dividends. The CDSC is 1% of the value of the shares redeemed for Class C. For the six months ended March 31, 2020, the CDSC for Class C shares aggregated $57. A deferred sales charge of up to 1% is assessed on certain redemptions of Class A shares. For the six months ended March 31, 2020, DDI received $19 for Class A shares.
Typesetting and Filing Service Fees. Under an agreement with the Fund, DIMA is compensated for providing certain pre-press and regulatory filing services to the Fund. For the six months ended March 31, 2020, the amount charged to the Fund by DIMA included in the Statement of Operations under Reports to shareholders aggregated $8,127, all of which is unpaid.
Trustees Fees and Expenses. The Fund paid retainer fees to each Trustee not affiliated with the Advisor, plus specified amounts to the Board Chairperson and to each committee Chairperson.
Affiliated Cash Management Vehicles. The Fund may invest uninvested cash balances in DWS Central Cash Management Government Fund and DWS ESG Liquidity Fund, affiliated money market funds which are managed by the Advisor. Each affiliated money market fund is managed in accordance with Rule 2a-7 under the 1940 Act, which governs the quality, maturity, diversity and liquidity of instruments in which a money market fund may invest. DWS Central Cash Management Government Fund seeks to maintain a stable net asset value, and DWS ESG Liquidity
32 | | | DWS CROCI® U.S. Fund |
Fund maintains a floating net asset value. The Fund indirectly bears its proportionate share of the expenses of each affiliated money market fund in which it invests. DWS Central Cash Management Government Fund does not pay the Advisor an investment management fee. To the extent that DWS ESG Liquidity Fund pays an investment management fee to the Advisor, the Advisor will waive an amount of the investment management fee payable to the Advisor by the Fund equal to the amount of the investment management fee payable on the Funds assets invested in DWS ESG Liquidity Fund.
D. Line of Credit
The Fund and other affiliated funds (the Participants) share in a $350 million revolving credit facility provided by a syndication of banks. The Fund may borrow for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. The Participants are charged an annual commitment fee, which is allocated based on net assets, among each of the Participants. Interest is calculated at a rate per annum equal to the sum of the Federal Funds Rate plus 1.25 percent plus if the one-month LIBOR exceeds the Federal Funds Rate, the amount of such excess. The Fund may borrow up to a maximum of 33 percent of its net assets under the agreement. The Fund had no outstanding loans at March 31, 2020.
E. Fund Share Transactions
The following table summarizes share and dollar activity in the Fund:
Six Months Ended March 31, 2020 |
Year Ended September 30, 2019 |
|||||||||||||||
Shares | Dollars | Shares | Dollars | |||||||||||||
Shares sold |
| |||||||||||||||
Class A | 287,563 | $ | 3,085,204 | 810,069 | $ | 8,520,724 | ||||||||||
Class C | 11,310 | 132,092 | 13,883 | 152,447 | ||||||||||||
Class R | 50,866 | 456,776 | 13,096 | 141,598 | ||||||||||||
Class R6 | 18 | 211 | 162 | 1,850 | ||||||||||||
Class S | 563,072 | 6,314,839 | 799,107 | 8,899,434 | ||||||||||||
Institutional Class | 941,651 | 11,174,423 | 576,967 | 6,554,697 | ||||||||||||
$ | 21,163,545 | $ | 24,270,750 |
DWS CROCI® U.S. Fund | | | 33 |
Six Months Ended March 31, 2020 |
Year Ended September 30, 2019 |
|||||||||||||||
Shares | Dollars | Shares | Dollars | |||||||||||||
Shares issued to shareholders in reinvestment of distributions |
| |||||||||||||||
Class A | 610,286 | $ | 7,475,998 | 443,613 | $ | 4,405,077 | ||||||||||
Class T | 58 | 712 | 38 | 372 | ||||||||||||
Class C | 13,396 | 162,897 | 13,043 | 128,606 | ||||||||||||
Class R | 7,423 | 91,003 | 5,796 | 57,611 | ||||||||||||
Class R6 | 759 | 9,295 | 504 | 5,000 | ||||||||||||
Class S | 3,194,358 | 39,098,601 | 2,335,884 | 23,171,306 | ||||||||||||
Institutional Class | 80,737 | 988,224 | 28,746 | 285,160 | ||||||||||||
$ | 47,826,730 | $ | 28,053,132 | |||||||||||||
Shares redeemed |
| |||||||||||||||
Class A | (1,149,561 | ) | $ | (13,201,819 | ) | (2,422,762 | ) | $ | (26,947,759 | ) | ||||||
Class C | (74,343 | ) | (861,483 | ) | (196,479 | ) | (2,192,703 | ) | ||||||||
Class R | (68,613 | ) | (636,410 | ) | (45,222 | ) | (509,115 | ) | ||||||||
Class R6 | (73 | ) | (896 | ) | (51 | ) | (503 | ) | ||||||||
Class S | (3,938,434 | ) | (45,189,066 | ) | (6,354,471 | ) | (70,363,153 | ) | ||||||||
Institutional Class | (995,861 | ) | (11,550,189 | ) | (707,083 | ) | (7,829,712 | ) | ||||||||
$ | (71,439,863 | ) | $ | (107,842,945 | ) | |||||||||||
Net increase (decrease) |
| |||||||||||||||
Class A | (251,712 | ) | $ | (2,640,617 | ) | (1,169,080 | ) | $ | (14,021,958 | ) | ||||||
Class T | 58 | 712 | 38 | 372 | ||||||||||||
Class C | (49,637 | ) | (566,494 | ) | (169,553 | ) | (1,911,650 | ) | ||||||||
Class R | (10,324 | ) | (88,631 | ) | (26,330 | ) | (309,906 | ) | ||||||||
Class R6 | 704 | 8,610 | 615 | 6,347 | ||||||||||||
Class S | (181,004 | ) | 224,374 | (3,219,480 | ) | (38,292,413 | ) | |||||||||
Institutional Class | 26,527 | 612,458 | (101,370 | ) | (989,855 | ) | ||||||||||
$ | (2,449,588 | ) | $ | (55,519,063 | ) |
F. Other
A novel strain of coronavirus (COVID-19) outbreak was declared a pandemic by the World Health Organization on March 11, 2020. The situation is evolving with various cities and countries around the world responding in different ways to address the outbreak. There are direct and indirect economic effects developing for various industries and individual companies throughout the world. Management will continue to monitor the impact COVID-19 has on the Fund and reflect the consequences as appropriate in the Funds accounting and financial reporting. The recent pandemic spread of the novel coronavirus and related geopolitical events could lead to increased market volatility, disruption to U.S. and world economies and markets and may have significant adverse effects on the Fund and its investments.
34 | | | DWS CROCI® U.S. Fund |
Information About Your Funds Expenses
As an investor of the Fund, you incur two types of costs: ongoing expenses and transaction costs. Ongoing expenses include management fees, distribution and service (12b-1) fees and other Fund expenses. Examples of transaction costs include sales charges (loads) and account maintenance fees, which are not shown in this section. The following tables are intended to help you understand your ongoing expenses (in dollars) of investing in the Fund and to help you compare these expenses with the ongoing expenses of investing in other mutual funds. In the most recent six-month period, the Fund limited these expenses for Class C, R, R6 and Institutional shares; had it not done so, expenses would have been higher. The example in the table is based on an investment of $1,000 invested at the beginning of the six-month period and held for the entire period (October 1, 2019 to March 31, 2020).
The tables illustrate your Funds expenses in two ways:
| Actual Fund Return. This helps you estimate the actual dollar amount of ongoing expenses (but not transaction costs) paid on a $1,000 investment in the Fund using the Funds actual return during the period. To estimate the expenses you paid over the period, simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the Expenses Paid per $1,000 line under the share class you hold. |
| Hypothetical 5% Fund Return. This helps you to compare your Funds ongoing expenses (but not transaction costs) with those of other mutual funds using the Funds actual expense ratio and a hypothetical rate of return of 5% per year before expenses. Examples using a 5% hypothetical fund return may be found in the shareholder reports of other mutual funds. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. |
Please note that the expenses shown in these tables are meant to highlight your ongoing expenses only and do not reflect any transaction costs. The Expenses Paid per $1,000 line of the tables is useful in comparing ongoing expenses only and will not help you determine the relative total expense of owning different funds. Subject to certain exceptions, an account maintenance fee of $20.00 assessed once per calendar year for Classes A, C and S shares may apply for accounts with balances less than $10,000. This fee is not included in these tables. If it was, the estimate of expenses paid for Classes A, C and S shares during the period would be higher, and account value during the period would be lower, by this amount.
DWS CROCI® U.S. Fund | | | 35 |
Expenses and Value of a $1,000 Investment for the six months ended March 31, 2020 (Unaudited) |
||||||||||||||||||||||||||||
Actual Fund Return |
Class A | Class T | Class C | Class R | Class R6 | Class S | Institutional Class |
|||||||||||||||||||||
Beginning Account Value 10/1/19 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | ||||||||||||||
Ending Account Value 3/31/20 | $ | 756.70 | $ | 757.50 | $ | 753.80 | $ | 755.70 | $ | 758.80 | $ | 758.80 | $ | 758.40 | ||||||||||||||
Expenses Paid per $1,000* | $ | 4.39 | $ | 3.95 | $ | 7.76 | $ | 5.66 | $ | 2.64 | $ | 2.90 | $ | 2.95 | ||||||||||||||
Hypothetical 5% Fund Return |
Class A | Class T | Class C | Class R | Class R6 | Class S | Institutional Class |
|||||||||||||||||||||
Beginning Account Value 10/1/19 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | $ | 1,000.00 | ||||||||||||||
Ending Account Value 3/31/20 | $ | 1,020.00 | $ | 1,020.50 | $ | 1,016.15 | $ | 1,018.55 | $ | 1,022.00 | $ | 1,021.70 | $ | 1,021.65 | ||||||||||||||
Expenses Paid per $1,000* | $ | 5.05 | $ | 4.55 | $ | 8.92 | $ | 6.51 | $ | 3.03 | $ | 3.34 | $ | 3.39 |
* | Expenses are equal to the Funds annualized expense ratio for each share class, multiplied by the average account value over the period, multiplied by 183 (the number of days in the most recent six-month period), then divided by 366. |
Annualized Expense Ratios |
Class A | Class T | Class C | Class R | Class R6 | Class S | Institutional Class |
|||||||||||||||||||||
DWS CROCI U.S. Fund | 1.00 | % | .90 | % | 1.77 | % | 1.29 | % | .60 | % | .66 | % | .67 | % |
For more information, please refer to the Funds prospectuses.
For an analysis of the fees associated with an investment in the Fund or similar funds, please refer to tools.finra.org/fund_analyzer/.
36 | | | DWS CROCI® U.S. Fund |
In accordance with Rule 22e-4 (the Liquidity Rule) under the Investment Company Act of 1940 (the 1940 Act), your Fund has adopted a liquidity risk management program (the Program), and the Board has designated DWS Investment Management Americas, Inc. (DIMA) as Program administrator. The Program is designed to assess and manage your Funds liquidity risk (the risk that the Fund would be unable to meet requests to redeem shares of the Fund without significant dilution of remaining investors interests in the Fund). DIMA has designated a committee (the Committee) composed of personnel from multiple departments within DIMA and its affiliates that is responsible for the implementation and ongoing administration of the Program, which includes assessing the Funds liquidity risk under both normal and reasonably foreseeable stressed conditions. Under the Program, every investment held by a fund is classified on a daily basis into one of four liquidity categories based on estimations of the investments ability to be sold during designated timeframes in current market conditions without significantly changing the investments market value.
In February 2020, as required by the Program and the Liquidity Rule, DIMA provided the Board with an annual written report (the Report) addressing the operation of the Program and assessing the adequacy and effectiveness of its implementation during the period from December 1, 2018 through November 30, 2019 (the Reporting Period). During the Reporting Period, your Fund was primarily invested in highly liquid investments (investments that the Fund anticipates can be converted to cash within three business days or less in current market conditions without significantly changing their market value). As a result, your Fund is not required to adopt, and has not adopted, a Highly Liquid Investment Minimum as defined in the Liquidity Rule. During the Reporting Period, the Fund did not approach the 15% limit imposed by the Liquidity Rule on holdings in illiquid investments (investments that cannot be sold or disposed of in seven days or less in current market conditions without the sale of the investment significantly changing the market value of the investment). Your Fund did not experience any issues meeting investor redemptions at any time during the Reporting Period. In the Report, DIMA stated that it believes the Program has operated adequately and effectively to manage the Funds liquidity risk during the Reporting Period. DIMA also reported on a material change made to the Program in May 2019 to address Securities and Exchange Commission guidance relating to extended foreign market holidays.
DWS CROCI® U.S. Fund | | | 37 |
Advisory Agreement Board Considerations and Fee Evaluation
The Board of Trustees (hereinafter referred to as the Board or Trustees) approved the renewal of DWS CROCI® U.S. Funds (the Fund) investment management agreement (the Agreement) with DWS Investment Management Americas, Inc. (DIMA) in September 2019.
In terms of the process that the Board followed prior to approving the Agreement, shareholders should know that:
| During the entire process, all of the Funds Trustees were independent of DIMA and its affiliates (the Independent Trustees). |
| The Board met frequently during the past year to discuss fund matters and dedicated a substantial amount of time to contract review matters. Over the course of several months, the Boards Contract Committee reviewed extensive materials received from DIMA, independent third parties and independent counsel. These materials included an analysis of the Funds performance, fees and expenses, and profitability from a fee consultant retained by the Funds Independent Trustees (the Fee Consultant). Based on its evaluation of the information provided, the Contract Committee presented its findings and recommendations to the Board. The Board then reviewed the Contract Committees findings and recommendations. |
| The Board also received extensive information throughout the year regarding performance of the Fund. |
| The Independent Trustees regularly met privately with counsel to discuss contract review and other matters. In addition, the Independent Trustees were advised by the Fee Consultant in the course of their review of the Funds contractual arrangements and considered a comprehensive report prepared by the Fee Consultant in connection with their deliberations. |
| In connection with reviewing the Agreement, the Board also reviewed the terms of the Funds Rule 12b-1 plan, distribution agreement, administrative services agreement, transfer agency agreement and other material service agreements. |
In connection with the contract review process, the Contract Committee and the Board considered the factors discussed below, among others. The Board also considered that DIMA has managed the Fund since its inception, and the Board believes that a long-term relationship with a capable, conscientious advisor is in the best interests of the Fund. The Board considered, generally, that shareholders chose to invest or remain
38 | | | DWS CROCI® U.S. Fund |
invested in the Fund knowing that DIMA managed the Fund. DIMA is part of DWS Group GmbH & Co. KGaA (DWS Group). DWS Group is a global asset management business that offers a wide range of investing expertise and resources, including research capabilities in many countries throughout the world. In 2018, approximately 20% of DWS Groups shares were sold in an initial public offering, with Deutsche Bank AG owning the remaining shares.
As part of the contract review process, the Board carefully considered the fees and expenses of each DWS fund overseen by the Board in light of the funds performance. In many cases, this led to the negotiation and implementation of expense caps. As part of these negotiations, the Board indicated that it would consider relaxing these caps in future years following sustained improvements in performance, among other considerations.
While shareholders may focus primarily on fund performance and fees, the Funds Board considers these and many other factors, including the quality and integrity of DIMAs personnel and administrative support services provided by DIMA, such as back-office operations, fund valuations, and compliance policies and procedures.
Nature, Quality and Extent of Services. The Board considered the terms of the Agreement, including the scope of advisory services provided under the Agreement. The Board noted that, under the Agreement, DIMA provides portfolio management services to the Fund and that, pursuant to a separate administrative services agreement, DIMA provides administrative services to the Fund. The Board considered the experience and skills of senior management and investment personnel and the resources made available to such personnel. The Board reviewed the Funds performance over short-term and long-term periods and compared those returns to various agreed-upon performance measures, including market index(es) and a peer universe compiled using information supplied by Morningstar Direct (Morningstar), an independent fund data service. The Board also noted that it has put into place a process of identifying Funds in Review (e.g., funds performing poorly relative to a peer universe), and receives additional reporting from DIMA regarding such funds and, where appropriate, DIMAs plans to address underperformance. The Board believes this process is an effective manner of identifying and addressing underperforming funds. Based on the information provided, the Board noted that, for the one- and three-year periods ended December 31, 2018, the Funds performance (Class A shares) was in the 4th quartile and 2nd quartile, respectively, of the applicable Morningstar universe (the 1st quartile being the best performers and the 4th quartile being the worst performers). The Board also observed that the Fund has underperformed its benchmark in the one- and three-year periods ended December 31, 2018. The Board noted
DWS CROCI® U.S. Fund | | | 39 |
the disappointing investment performance of the Fund in recent periods and continued to discuss with senior management of DIMA the factors contributing to such underperformance and actions being taken to improve performance. The Board recognized the efforts by DIMA in recent years to enhance its investment platform and improve long-term performance across the DWS fund complex.
Fees and Expenses. The Board considered the Funds investment management fee schedule, operating expenses and total expense ratios, and comparative information provided by Broadridge Financial Solutions, Inc. (Broadridge) and the Fee Consultant regarding investment management fee rates paid to other investment advisors by similar funds (1st quartile being the most favorable and 4th quartile being the least favorable). With respect to management fees paid to other investment advisors by similar funds, the Board noted that the contractual fee rates paid by the Fund, which include a 0.10% fee paid to DIMA under the Funds administrative services agreement, were lower than the median (1st quartile) of the applicable Broadridge peer group (based on Broadridge data provided as of December 31, 2018). The Board noted that the Funds Class A shares total (net) operating expenses (excluding 12b-1 fees) were expected to be higher than the median (3rd quartile) of the applicable Broadridge expense universe (based on Broadridge data provided as of December 31, 2018, and analyzing Broadridge expense universe Class A (net) expenses less any applicable 12b-1 fees) (Broadridge Universe Expenses). The Board also reviewed data comparing each other operational share classs total (net) operating expenses to the applicable Broadridge Universe Expenses. The Board noted that the expense limitations agreed to by DIMA were expected to help the Funds total (net) operating expenses remain competitive. The Board considered the Funds management fee rate as compared to fees charged by DIMA to comparable DWS U.S. registered funds (DWS Funds) and considered differences between the Fund and the comparable DWS Funds. The information requested by the Board as part of its review of fees and expenses also included information about institutional accounts (including any sub-advised funds and accounts) and funds offered primarily to European investors (DWS Europe Funds) managed by DWS Group. The Board noted that DIMA indicated that DWS Group does not manage any institutional accounts or DWS Europe Funds comparable to the Fund.
On the basis of the information provided, the Board concluded that management fees were reasonable and appropriate in light of the nature, quality and extent of services provided by DIMA.
Profitability. The Board reviewed detailed information regarding revenues received by DIMA under the Agreement. The Board considered the estimated costs to DIMA, and pre-tax profits realized by DIMA, from
40 | | | DWS CROCI® U.S. Fund |
advising the DWS Funds, as well as estimates of the pre-tax profits attributable to managing the Fund in particular. The Board also received information regarding the estimated enterprise-wide profitability of DIMA and its affiliates with respect to all fund services in totality and by fund. The Board and the Fee Consultant reviewed DIMAs methodology in allocating its costs to the management of the Fund. Based on the information provided, the Board concluded that the pre-tax profits realized by DIMA in connection with the management of the Fund were not unreasonable. The Board also reviewed certain publicly available information regarding the profitability of certain similar investment management firms. The Board noted that, while information regarding the profitability of such firms is limited (and in some cases is not necessarily prepared on a comparable basis), DIMA and its affiliates overall profitability with respect to the DWS Funds (after taking into account distribution and other services provided to the funds by DIMA and its affiliates) was lower than the overall profitability levels of most comparable firms for which such data was available.
Economies of Scale. The Board considered whether there are economies of scale with respect to the management of the Fund and whether the Fund benefits from any economies of scale. The Board noted that the Funds investment management fee schedule includes fee breakpoints. The Board concluded that the Funds fee schedule represents an appropriate sharing between the Fund and DIMA of such economies of scale as may exist in the management of the Fund at current asset levels.
Other Benefits to DIMA and Its Affiliates. The Board also considered the character and amount of other incidental or fall-out benefits received by DIMA and its affiliates, including any fees received by DIMA for administrative services provided to the Fund, any fees received by an affiliate of DIMA for transfer agency services provided to the Fund and any fees received by an affiliate of DIMA for distribution services. The Board noted that DIMA pays a licensing fee to an affiliate related to the Funds use of the CROCI® strategy. The Board also considered benefits to DIMA related to brokerage and soft-dollar allocations, including allocating brokerage to pay for research generated by parties other than the executing broker dealers, which pertain primarily to funds investing in equity securities. In addition, the Board considered the incidental public relations benefits to DIMA related to DWS Funds advertising and cross-selling opportunities among DIMA products and services. The Board considered these benefits in reaching its conclusion that the Funds management fees were reasonable.
Compliance. The Board considered the significant attention and resources dedicated by DIMA to its compliance processes in recent years. The Board noted in particular (i) the experience, seniority and time commitment of the individuals serving as DIMAs and the Funds chief
DWS CROCI® U.S. Fund | | | 41 |
compliance officers and (ii) the substantial commitment of resources by DIMA and its affiliates to compliance matters, including the retention of compliance personnel.
Based on all of the information considered and the conclusions reached, the Board determined that the continuation of the Agreement is in the best interests of the Fund. In making this determination, the Board did not give particular weight to any single factor identified above. The Board considered these factors over the course of numerous meetings, certain of which were in executive session with only the Independent Trustees and counsel present. It is possible that individual Independent Trustees may have weighed these factors differently in reaching their individual decisions to approve the continuation of the Agreement.
42 | | | DWS CROCI® U.S. Fund |
For More Information | The automated telephone system allows you to access personalized account information and obtain information on other DWS funds using either your voice or your telephone keypad. Certain account types within Classes A, T, C and S also have the ability to purchase, exchange or redeem shares using this system.
For more information, contact your financial representative. You may also access our automated telephone system or speak with a Shareholder Service representative by calling:
(800) 728-3337 | |
Web Site | dws.com
View your account transactions and balances, trade shares, monitor your asset allocation, subscribe to fund and account updates by e-mail, and change your address, 24 hours a day.
Obtain prospectuses and applications, news about DWS funds, insight from DWS economists and investment specialists and access to DWS fund account information. | |
Written Correspondence | DWS
PO Box 219151 Kansas City, MO 64121-9151 | |
Proxy Voting | The Funds policies and procedures for voting proxies for portfolio securities and information about how the Fund voted proxies related to its portfolio securities during the most recent 12-month period ended June 30 are available on our Web site dws.com/en-us/resources/proxy-voting or on the SECs Web site sec.gov. To obtain a written copy of the Funds policies and procedures without charge, upon request, call us toll free at (800) 728-3337. | |
Portfolio Holdings | Following the Funds fiscal first and third quarter-end, a complete portfolio holdings listing is filed with the SEC on Form N-PORT. The Funds Form N-PORT will be available on the SECs Web site at sec.gov. The Funds portfolio holdings are also posted on dws.com from time to time. Please see the Funds current prospectus for more information. | |
Principal Underwriter | If you have questions, comments or complaints, contact:
DWS Distributors, Inc.
222 South Riverside Plaza Chicago, IL 60606-5808 (800) 621-1148 |
DWS CROCI® U.S. Fund | | | 43 |
Investment Management | DWS Investment Management Americas, Inc. (DIMA or the Advisor), which is part of the DWS Group GmbH & Co. KGaA (DWS Group), is the investment advisor for the Fund. DIMA and its predecessors have more than 90 years of experience managing mutual funds and DIMA provides a full range of investment advisory services to both institutional and retail clients. DIMA is an indirect, wholly owned subsidiary of DWS Group.
DWS Group is a global organization that offers a wide range of investing expertise and resources, including hundreds of portfolio managers and analysts and an office network that reached the worlds major investment centers. This well-resourced global investment platform brings together a wide variety of experience and investment insight across industries, regions, asset classes and investing styles. | |||||||||
Class A | Class T | Class C | Class S | Institutional Class | ||||||
Nasdaq Symbol | DCUAX | DCUUX | DCUCX | DCUSX | DCUIX | |||||
CUSIP Number | 25157M 588 | 25157M 448 | 25157M 570 | 25157M 547 | 25157M 554 | |||||
Fund Number | 1020 | 1720 | 1320 | 2020 | 1420 | |||||
For shareholders of Class R and R6 | ||||||||||
Automated Information Line | DWS/Ascensus Plan Access (800) 728-3337
24-hour access to your retirement plan account. | |||||||||
Web Site | dws.com
Obtain prospectuses and applications, news about DWS funds, insight from DWS economists and investment specialists and access to Deutsche fund account information.
Log in/register to manage retirement account assets at https://www.mykplan.com/participantsecure_net/login.aspx. | |||||||||
For More Information | (800) 728-3337
To speak with a service representative. | |||||||||
Written Correspondence | DWS Service Company
222 South Riverside Plaza Chicago, IL 60606-5806 | |||||||||
Class R | Class R6 | |||||||||
Nasdaq Symbol | DCUTX | DCURX |
|
|
| |||||
CUSIP Number | 25157M 513 | 25157M 562 |
|
|
| |||||
Fund Number | 1520 | 1620 |
|
|
|
44 | | | DWS CROCI® U.S. Fund |
FACTS | What Does DWS Do With Your Personal Information? | |
Why? | Financial companies choose how they share your personal information. Federal law gives consumers the right to limit some but not all sharing. Federal law also requires us to tell you how we collect, share and protect your personal information. Please read this notice carefully to understand what we do. | |
What? | The types of personal information we collect and share can include:
Social Security number
Account balances
Purchase and transaction history
Bank account information
Contact information such as mailing address, e-mail address and telephone number | |
How? | All financial companies need to share customers personal information to run their everyday business. In the section below, we list the reasons financial companies can share their customers personal information, the reasons DWS chooses to share and whether you can limit this sharing. |
Reasons we can share your personal information |
Does DWS share? | Can you limit this sharing? | ||
For our everyday business purposes such as to process your transactions, maintain your account(s), respond to court orders or legal investigations |
Yes | No | ||
For our marketing purposes to offer our products and services to you | Yes | No | ||
For joint marketing with other financial companies | No | We do not share | ||
For our affiliates everyday business purposes information about your transactions and experiences | No | We do not share | ||
For our affiliates everyday business purposes information about your creditworthiness | No | We do not share | ||
For non-affiliates to market to you | No | We do not share |
Questions? | Call (800) 728-3337 or e-mail us at service@dws.com |
DWS CROCI® U.S. Fund | | | 45 |
| ||
Who we are | ||
Who is providing this notice? | DWS Distributors, Inc; DWS Investment Management Americas, Inc.; DWS Trust Company; the DWS Funds | |
What we do | ||
How does DWS protect my personal information? | To protect your personal information from unauthorized access and use, we use security measures that comply with federal law. These measures include computer safeguards, secured files, and secured buildings. | |
How does DWS collect my personal information? | We collect your personal information, for example, when you:
open an account
give us your contact information
provide bank account information for ACH or wire transactions
tell us where to send money
seek advice about your investments | |
Why cant I limit all sharing? | Federal law gives you the right to limit only
sharing for affiliates everyday business purposes
information about your creditworthiness
affiliates from using your information to market to you
sharing for non-affiliates to market to you
State laws and individual companies may give you additional rights to limit sharing. | |
Definitions | ||
Affiliates | Companies related by common ownership or control. They can be financial or non-financial companies. Our affiliates include financial companies with the DWS or Deutsche Bank (DB) name, such as DB AG Frankfurt. | |
Non-affiliates | Companies not related by common ownership or control. They can be financial and non-financial companies.
Non-affiliates we share with include account service providers, service quality monitoring services, mailing service providers and verification services to help in the fight against money laundering and fraud. | |
Joint marketing | A formal agreement between non-affiliated financial companies that together market financial products or services to you. DWS does not jointly market. |
California residents may go to https://fundsus.dws.com/us/en-us/legal-resources/privacy-policy.html to obtain additional information relating to their rights under California state law.
Rev. 12/2019
46 | | | DWS CROCI® U.S. Fund |
Notes
DCUS-3
(R-046067-5 5/20)
ITEM 2. | CODE OF ETHICS | |
Not applicable. | ||
ITEM 3. | AUDIT COMMITTEE FINANCIAL EXPERT | |
Not applicable | ||
ITEM 4. | PRINCIPAL ACCOUNTANT FEES AND SERVICES | |
Not applicable | ||
ITEM 5. | AUDIT COMMITTEE OF LISTED REGISTRANTS | |
Not applicable | ||
ITEM 6. | SCHEDULE OF INVESTMENTS | |
Not applicable | ||
ITEM 7. | DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES | |
Not applicable | ||
ITEM 8. | PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES | |
Not applicable | ||
ITEM 9. | PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS | |
Not applicable | ||
ITEM 10. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS | |
There were no material changes to the procedures by which shareholders may recommend nominees to the Fund’s Board. The primary function of the Nominating and Governance Committee is to identify and recommend individuals for membership on the Board and oversee the administration of the Board Governance Guidelines. Shareholders may recommend candidates for Board positions by forwarding their correspondence by U.S. mail or courier service to Keith R. Fox, DWS Funds Board Chair, c/o Thomas R. Hiller, Ropes & Gray LLP, Prudential Tower, 800 Boylston Street, Boston, MA 02199-3600. | ||
ITEM 11. | CONTROLS AND PROCEDURES | |
(a) | The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report. | |
(b) | There have been no changes in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting. | |
ITEM 12. | Disclosure of Securities Lending Activities for Closed-End Management Investment Companies. | |
Not applicable | ||
ITEM 13. | EXHIBITS | |
(a)(1) | Not applicable | |
(a)(2) | Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT. | |
(b) | Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) is furnished and attached hereto as Exhibit 99.906CERT. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant: | DWS CROCI® U.S. Fund, a series of Deutsche DWS Investment Trust |
By: |
/s/Hepsen Uzcan Hepsen Uzcan President |
Date: | 5/29/2020 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: |
/s/Hepsen Uzcan Hepsen Uzcan President |
Date: | 5/29/2020 |
By: |
/s/Diane Kenneally Diane Kenneally Chief Financial Officer and Treasurer |
Date: | 5/29/2020 |
President
Form N-CSRS Certification under Sarbanes Oxley Act
I, Hepsen Uzcan, certify that:
1) | I have reviewed this report, filed on behalf of DWS CROCI® U.S. Fund, a series of Deutsche DWS Investment Trust, on Form N-CSRS; | ||
2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | ||
3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report; | ||
4) | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have: | ||
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | ||
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | ||
c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and | ||
d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | ||
5) | The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): | ||
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and | ||
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting | ||
5/29/2020 | /s/Hepsen Uzcan |
Hepsen Uzcan | |
President |
Chief Financial Officer and Treasurer
Form N-CSRS Certification under Sarbanes Oxley Act
I, Diane Kenneally, certify that:
1) | I have reviewed this report, filed on behalf of DWS CROCI® U.S. Fund, a series of Deutsche DWS Investment Trust, on Form N-CSRS; | ||
2) | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | ||
3) | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report; | ||
4) | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have: | ||
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | ||
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | ||
c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and | ||
d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | ||
5) | The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): | ||
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and | ||
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting | ||
5/29/2020 | /s/Diane Kenneally |
Diane Kenneally | |
Chief Financial Officer and Treasurer |
President
Section 906 Certification under Sarbanes Oxley Act
I, Hepsen Uzcan, certify that:
1. | I have reviewed this report, filed on behalf of DWS CROCI® U.S. Fund, a series of Deutsche DWS Investment Trust, on Form N-CSRS; |
2. | Based on my knowledge and pursuant to 18 U.S.C. § 1350, the periodic report on Form N-CSRS (the “Report”) fully complies with the requirements of § 13 (a) or § 15 (d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
5/29/2020 | /s/Hepsen Uzcan |
Hepsen Uzcan | |
President |
Chief Financial Officer and Treasurer
Section 906 Certification under Sarbanes Oxley Act
I, Diane Kenneally, certify that:
1. | I have reviewed this report, filed on behalf of DWS CROCI® U.S. Fund, a series of Deutsche DWS Investment Trust, on Form N-CSRS; |
2. | Based on my knowledge and pursuant to 18 U.S.C. § 1350, the periodic report on Form N-CSRS (the “Report”) fully complies with the requirements of § 13 (a) or § 15 (d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
5/29/2020 | /s/Diane Kenneally |
Diane Kenneally | |
Chief Financial Officer and Treasurer |
$$[)B-X03M4:&4@
M9F]L;&]W:6YG(&9O;G1S(&%R92!P $$[)B-X03M4:&4@
M9F]L;&]W:6YG(&9O;G1S(&%R92!P .,*KC-
M,660QYW@K ERUC=2G%N
M2OJ=V;R7@II&D4%$O>05$W2I=F'?'U.+[OP6&L7PRO'NM&:PG*00F?IUD+AW
M"N1M*) @[WO73U=?5FE\*MY1SUC]]XOC/S%E2N;7Y9HK=
MREN)4[EZ:+PM*:)"A=1M+%3]3F*E O\ RRQJ_F$E- 4+?J,T6B+.&'?0HTH7
M06M?)C^524X2TO(^9.%"YU/\D[%7ORSDQ)1,71R<2MV+V%!07=$05%!0T5135)!1#A!-F(K5UAN9GHW
%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6
M,DMU>%8F(WA!.S)+=7A6,DMU>%8R2W!0<%=R6%8Q971$2T8T0E=);TM(66HS
M=W$X:SAY*V)V>F]T-S-Z0D)P;')Q5'(Y6DLV8D]M;DQ*2&)22F,O0T$F(WA!
M.VAT=C-X:VA1CAU=S$O>4QM5VYV
M.$%::7(X='-65VIY6#5P=6@O<#)V45=W8C=55VXV9&)P5#535"MS,S19<794
M.'%F3&HF(WA!.W1854QN54Y32#AL>&1/<6(O=T-20C9++VAJ87!N6F9L+W=#
M4TQ)053#,U6595+TI8*T5V.%@R6#9.+U-F,7(Y0DHY5BLF(WA!
M.W-E;#E4*W(Q9S5C=E,S*W,X9E(U8W8R855X5C93855.96YE=4)8:4AL1"]!
M6'%1.&8P;C961RMP+W!(-G8V+W%E;F4O5W$P+V1E:CDF(WA!.U@Y3#=(=S Y
M3#-W;V5J9FQL*VEV.$=79C9,*W9F5G95=758-E4T+UA05RMS>65T-C-$-&$K
M
G4Z)1G!#B8NE+G+_!:+!#3+&L.&
M5)7\VM*QG]%%(!7,4?YO-)*X^-VA88O%VM4\OCJI G*/4FEH6U&H4;(2D'JC
M]@T2F(./,+*&&)YJ_P!L!Q\;H5*YQ-*?Y45FA8(33UHQYML.I&N/NEF5;>%O
M0^DX78$",!-5K*8UDS.=QD<@C\N>8C/F9E7A
0MK66X(7V6+IK*6"M9;7W(
M:*PJ+.4Y< +'*:R9F-LV*ENZA
5//GC.G8^1[,A;GV^OL['D3V?VNOT=.O7Z,0\8<:P65
MJ2:VO3.\E^.:'9L=2NFA>-;5Z5<7V=^S?;2FFAZ;^C?7IO(#)X P!@&L2.;0
MR'$>4RZ71B*IM!V/:B1O[4QD=C77J/QKFK2E]G73?47:Z>K?KP"MD?@G E:+KY'F?OKOD?@G E:+KY'F?OKOD?@G E:+KY'F?
MOKOD?@G E:+KY'F?OKOD?@G E:+KY'F?OKOD?@G
M E:+KY'F?OKOD?@G E:+KY'F?OKOD?@G E:+KY'F?OKO